Australia markets closed

Race Oncology Limited (RAC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
1.3100+0.0200 (+1.55%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Operating expenses
Research development
9,622
9,622
6,822
2,820
1,720
Selling general and administrative
1,768
1,768
3,959
2,913
1,681
Total operating expenses
13,650
13,650
11,964
6,784
4,112
Operating income or loss
-13,650
-13,650
-11,964
-6,784
-4,112
Total other income/expenses net
3,134
3,134
707.807
424.885
256.44
Income before tax
-9,923
-9,923
-11,202
-6,340
-3,846
Income tax expense
0
0
0
0
0
Income from continuing operations
-9,923
-9,923
-11,202
-6,340
-3,846
Net income
-9,923
-9,923
-11,202
-6,340
-3,846
Net income available to common shareholders
-9,923
-9,923
-11,202
-6,340
-3,846
Basic EPS
-0.06
-
-0.07
-0.05
-0.04
Diluted EPS
-0.06
-
-0.07
-0.05
-0.04
Basic average shares
160,721
-
153,310
130,964
106,595
Diluted average shares
160,721
-
153,310
130,964
106,595